Literature DB >> 8419183

Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism.

A Rot1.   

Abstract

The role of leukocyte migration induced by the substrate-bound attractants is obscured by the inability of standard methods for the study of leukocyte migration to dissociate chemotaxis and haptotaxis, migration in response to soluble and surface-bound gradients of attractants. Here we show that the gradient of neutrophil attractant/activation protein-1 (interleukin-8, NAP-1/IL-8) induces directed in vitro neutrophil migration when bound to the polycarbonate filter. In addition, we suggest that haptotaxis is responsible for neutrophil migration induced by NAP-1/IL-8 in standard Boyden-type chemotaxis assays and, in light of the ability of NAP-1/IL-8 to bind to the endothelial cell surface and the extracellular matrix, could also be of great significance in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419183     DOI: 10.1002/eji.1830230150

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  59 in total

1.  RelB regulation of chemokine expression modulates local inflammation.

Authors:  Y Xia; M E Pauza; L Feng; D Lo
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 2.  Rho GTPases and leucocyte-induced endothelial remodelling.

Authors:  Jaime Millán; Anne J Ridley
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

3.  Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.

Authors:  Pauline Bonvin; Franck Gueneau; Vanessa Buatois; Maud Charreton-Galby; Stanley Lasch; Marie Messmer; Urs Christen; Andrew D Luster; Zoë Johnson; Walter Ferlin; Marie Kosco-Vilbois; Amanda Proudfoot; Nicolas Fischer
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

4.  Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits.

Authors:  R A Dumont; B D Car; N N Voitenok; U Junker; B Moser; O Zak; T O'Reilly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.

Authors:  S Jovic; H M Linge; M M Shikhagaie; A I Olin; L Lannefors; J S Erjefält; M Mörgelin; A Egesten
Journal:  Mucosal Immunol       Date:  2015-05-20       Impact factor: 7.313

6.  CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.

Authors:  Heather D Hickman; Glennys V Reynoso; Barbara F Ngudiankama; Stephanie S Cush; James Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

7.  Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.

Authors:  Amanda E I Proudfoot; Tracy M Handel; Zoë Johnson; Elaine K Lau; Patricia LiWang; Ian Clark-Lewis; Frédéric Borlat; Timothy N C Wells; Marie H Kosco-Vilbois
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

8.  Interleukin-8 production by human mesothelial cells after direct stimulation with staphylococci.

Authors:  C E Visser; J J Steenbergen; M G Betjes; S Meijer; L Arisz; E C Hoefsmit; R T Krediet; R H Beelen
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Heparin potentiates in vivo neutrophil migration induced by IL-8.

Authors:  M Dias-Baruffi; G Pereira-da-Silva; M C Jamur; M C Roque-Barreira
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

10.  Neutrophil haptotaxis induced by the lectin KM+.

Authors:  L Ganiko; A R Martins; E M Espreáfico; M C Roque-Barreira
Journal:  Glycoconj J       Date:  1998-05       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.